Highlights
NASDAQ: ADMS       Adamas Pharma
Last Price Today's Change   Day's Range   Trading Volume
5.33   +0.17 (3.29%)  5.05 - 5.33  392,425

Overview

 
Avg Volume (4 weeks):339,521
4 Weeks Range:4.43 - 5.44
4 Weeks Price Volatility (%):
89.11%
52 Weeks Range:2.43 - 9.15
52 Weeks Price Volatility (%):
43.15%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Adamas Pharmaceuticals Inc was incorporated in the State of Delaware on November 15, 2000. It is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102 (amantadine hydrochloride) for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia. The Company's portfolio also includes two drugs commercially available in the United States for indications relating to Alzheimer's disease: Namzaric capsules and Namenda XR extended release capsules.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5555  1341  319  3337 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 0.869+0.027 
 OCGN 6.50+0.98 
 WBT 22.58+6.95 
 SKLZ 16.76+4.21 
 CTRM 0.478+0.028 
 ATHE 1.44+0.19 
 NIO 38.90+1.97 
 SNSS 5.32+1.04 
 NAKD 0.547+0.029 
 AAPL 133.50+0.39 

TOP ARTICLES

1. CryptoNews of the Week CryptoNews
2. Daily Futures Trading Strategy 21 April 2021 Where Futures Lies
3. Wall Street Breakfast: Coming Of Age? Wall Street Breakfast
4. Equities Dipped Further on Virus Resurgence State of The Markets
5. Bulls Took A Breather Amid Profit Taking State of The Markets